Safe and effective prescribing: A new and important initiative from the PhRMA Foundation
By Eileen Cannon | September 26, 2018
Safe and effective prescribing is a critically important part of the equation for successful medical treatment in today’s health care system. Yet data from the Association of American Colleges...
Read More
PhRMA comments in response to request for information on competitive bidding program in Medicare Part B
By Nicole Longo | September 25, 2018
Yesterday, the Pharmaceutical Research and Manufacturers of America (PhRMA) submitted comments in response to the recent 2019 Hospital Outpatient Prospective Payment System proposed rule,...
Read More
New report shows more than 300 skin disease medicines in development
By Andrew Powaleny | September 25, 2018
More than 100 million Americans – one third of the U.S. population – suffer from skin conditions.
Read More
Experts agree: the Bipartisan Budget Act changes to Medicare Part D jeopardize the program
By Juliet Johnson | September 24, 2018
The changes made to Part D in the Bipartisan Budget Act (BBA) that passed in February threaten the program’s successful competitive structure. While these changes closed the donut hole a year...
Read More
Five myths about global efforts to combat tuberculosis
By Megan Van Etten | September 20, 2018
On September 26, world leaders will convene in New York for the first-ever United Nations (UN) High-Level Meeting on Ending Tuberculosis (TB). This event could not be more critical – or more...
Read More
New whitepaper identifies reasons why ICER’s cost-effectiveness analyses are not useful for payers
By Lauren Neves | September 19, 2018
A new whitepaper authored by Bruce Pyenson, F.S.A., M.A.A.A. and colleagues from Milliman explains why Institute for Clinical and Economic Review (ICER) cost-effective analyses (CEAs) will not be...
Read More
Saving kids and dogs from shared cancers
By Guest Contributor | September 17, 2018
Ulrike Szalay is the Founder and Executive Director of Canines-N-Kids Foundation Did you know? Dogs and children spontaneously develop a number of similar cancers. In fact, cancer is the leading...
Read More
What if a couple of small fixes could protect seniors in the donut hole and save them money on out-of-pocket costs?
By Juliet Johnson | September 13, 2018
Right now, Congress has the opportunity to make two small fixes that will protect seniors in the Medicare Part D donut hole and save them money on out-of-pocket costs for their medicines. These...
Read More
New report details the setbacks and challenges to Alzheimer’s research
By Gretta Stone | September 12, 2018
Illustrating the challenges of developing medicines to fight Alzheimer’s disease, a new analysis found that between 1998 and 2017, there were 146 unsuccessful medicines in clinical trials for...
Read More
Disrupting Alzheimer's
By Andrew Powaleny | September 10, 2018
We are living in a new era of medicine, where treatments and even cures once believed to be impossible are today a reality. But this immense progress does not apply universally and there have been...
Read More
Medicare Monday (100)
340B Spotlight (37)
Cost & Consequence (0)
